ClinicalTrials.Veeva

Menu

Platelet-rich Plasma (PRP) Treatment for Medial Retinaculum Tear Post Medial Patellar Dislocation

Clalit Health Services logo

Clalit Health Services

Status and phase

Completed
Phase 3
Phase 2

Conditions

Patella-Dislocation

Treatments

Biological: Plasma Rich in Growth Factors (PRGF)
Drug: placebo

Study type

Interventional

Funder types

Other

Identifiers

Details and patient eligibility

About

To check the influence of injected platelet-rich plasma (PRP) on the healing of medial retinaculum and the redaction in recurrent dislocation of the patella.

Full description

Autologous platelet-rich matrices may aid in the healing of ligaments & tendons by promoting and accelerating tissue healing because of the release of growth factors including transforming growth factor (TGF)-beta1 and platelet-derived growth factor (PDGF) from platelet alpha-granules.

Enrollment

50 estimated patients

Sex

All

Ages

18 to 40 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • age 18-40 years old
  • first time patella dislocation

Exclusion criteria

  • pregnancy
  • mental or physical disabilities

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

50 participants in 2 patient groups, including a placebo group

2
Placebo Comparator group
Description:
saline
Treatment:
Drug: placebo
1
Experimental group
Description:
Plasma Rich in Growth Factors (PRGF)
Treatment:
Biological: Plasma Rich in Growth Factors (PRGF)

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems